Clinical characteristics of coronavirus disease 2019 in patients undergoing laparoscopic bariatric/metabolic surgery: a nationwide survey in Japan

期刊论文
发表日期：

2024年12月3日

查看全文

Yasuhiro Miyazaki,
Masayuki Ohta,
Seiichi Kitahama,
Yosuke Seki,
Susumu Inamine,
Takashi Oshiro,
Yoshihiro Nagao,
Fumihiko Hatao,
Hajime Orita,
Akira Sasaki,
Shunsuke Kagawa,
Tsuyoshi Yamaguchi,
Keiji Aizu,
Keiji Hayata,
Shin Saito,
Manabu Amiki,
Yoji Nakamura,
Hisahiro Matsubara,
Mitsuo Shimada,
Takeshi Naitoh,
Nobuya Ishibashi,
Shuji Takiguchi,
Kazunori Shibao,
Kentaro Inoue,
Takeshi Togawa,
Takuro Saito,
Kohei Uno,
Yuichi Endo,
Kazunori Kasama,
Ichiro Tatsuno

摘要

Purpose

Bariatric/metabolic surgery has been reported to reduce the incidence of severe coronavirus disease 2019 (COVID-19); however, its ability to reduce risk is controversial. Therefore, this study aimed to elucidate the incidence and severity of COVID-19 in bariatric patients in Japan.

Methods

The first survey of patients infected with COVID-19 after bariatric/metabolic surgery until June 30, 2022, was sent to 83 Japanese institutions. A second survey was conducted in institutions that reported on COVID-19 patients. The severity of COVID-19 was compared between the general population and bariatric patients, and risk factors correlated with severity were also evaluated.

Results

Twenty-six institutions (31.3%) reported 119 patients with COVID-19 after laparoscopic bariatric/metabolic surgery. There were no severe cases or deaths; however, moderate COVID-19 (pneumonia) was significantly more common in bariatric patients than in the general population (11.4% vs. 1.3%). The risk factors for moderate COVID-19 in bariatric patients included incurable dyslipidemia and infection before the 6th wave of the pandemic.

Conclusion

In Japan, the number of moderate COVID-19 cases may be higher in bariatric patients than in the general population. This study did not show that bariatric/metabolic surgery reduces the risk of COVID-19 complications.